annual D&A:
$79.00K+$6000.00(+8.22%)Summary
- As of today (September 13, 2025), SPRY annual depreciation & amortization is $79.00 thousand, with the most recent change of +$6000.00 (+8.22%) on December 31, 2024.
- During the last 3 years, SPRY annual D&A has fallen by -$134.00 thousand (-62.91%).
- SPRY annual D&A is now -95.38% below its all-time high of $1.71 million, reached on December 1, 2020.
Performance
SPRY Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$279.00K-$1000.00(-0.36%)Summary
- As of today (September 13, 2025), SPRY quarterly depreciation & amortization is $279.00 thousand, with the most recent change of -$1000.00 (-0.36%) on June 30, 2025.
- Over the past year, SPRY quarterly D&A has increased by +$261.00 thousand (+1450.00%).
- SPRY quarterly D&A is now -48.43% below its all-time high of $541.00 thousand, reached on September 1, 2021.
Performance
SPRY quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$609.00K+$261.00K(+75.00%)Summary
- As of today (September 13, 2025), SPRY TTM depreciation & amortization is $609.00 thousand, with the most recent change of +$261.00 thousand (+75.00%) on June 30, 2025.
- Over the past year, SPRY TTM D&A has increased by +$547.00 thousand (+882.26%).
- SPRY TTM D&A is now -68.43% below its all-time high of $1.93 million, reached on December 1, 2021.
Performance
SPRY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SPRY Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.2% | +1450.0% | +882.3% |
| 3 y3 years | -62.9% | +854.0% | -38.1% |
| 5 y5 years | -94.9% | -30.8% | -24.3% |
SPRY Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.2% | +8.2% | -0.4% | +3885.7% | at high | +6190.0% |
| 5 y | 5-year | -95.4% | +8.2% | -48.4% | +854.0% | -68.4% | +6190.0% |
| alltime | all time | -95.4% | +8.2% | -48.4% | +854.0% | -68.4% | +6190.0% |
SPRY Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $279.00K(-0.4%) | $609.00K(+75.0%) |
| Mar 2025 | - | $280.00K(+865.5%) | $348.00K(+340.5%) |
| Dec 2024 | $79.00K(+8.2%) | $29.00K(+38.1%) | $79.00K(+27.4%) |
| Sep 2024 | - | $21.00K(+16.7%) | $62.00K(0.0%) |
| Jun 2024 | - | $18.00K(+63.6%) | $62.00K(-3.1%) |
| Mar 2024 | - | $11.00K(-8.3%) | $64.00K(-12.3%) |
| Dec 2023 | $73.00K(-77.1%) | $12.00K(-42.9%) | $73.00K(+19.7%) |
| Sep 2023 | - | $21.00K(+5.0%) | $61.00K(+29.8%) |
| Jun 2023 | - | $20.00K(0.0%) | $47.00K(-570.0%) |
| Mar 2023 | - | $20.00K(+185.7%) | -$10.00K(-102.2%) |
| Dec 2022 | $319.00K | - | - |
| Sep 2022 | - | $7000.00(-118.9%) | $450.00K(-54.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$37.00K(-174.0%) | $984.00K(-35.0%) |
| Mar 2022 | - | $50.00K(-88.4%) | $1.51M(-21.6%) |
| Dec 2021 | $213.00K(-87.5%) | - | - |
| Dec 2021 | - | $430.00K(-20.5%) | $1.93M(+28.7%) |
| Sep 2021 | - | $541.00K(+10.0%) | $1.50M(+56.5%) |
| Jun 2021 | - | $492.00K(+5.6%) | $958.00K(+10.2%) |
| Mar 2021 | - | $466.00K(+15.6%) | $869.00K(+8.1%) |
| Dec 2020 | $1.71M(+10.6%) | - | - |
| Jun 2020 | - | $403.00K(+0.5%) | $804.00K(+100.5%) |
| Mar 2020 | - | $401.00K | $401.00K |
| Dec 2019 | $1.55M(+8.9%) | - | - |
| Dec 2018 | $1.42M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is ARS Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of SPRY is $79.00K
What is the all time high annual D&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $1.71M
What is ARS Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, SPRY annual depreciation & amortization has changed by +$6000.00 (+8.22%)
What is ARS Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of SPRY is $279.00K
What is the all time high quarterly D&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $541.00K
What is ARS Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, SPRY quarterly depreciation & amortization has changed by +$261.00K (+1450.00%)
What is ARS Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of SPRY is $609.00K
What is the all time high TTM D&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $1.93M
What is ARS Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, SPRY TTM depreciation & amortization has changed by +$547.00K (+882.26%)